| 注册
首页|期刊导航|中国临床药理学杂志|5-氟尿嘧啶联合亚叶酸钙与奥沙利铂化疗方案治疗晚期结直肠癌的临床研究

5-氟尿嘧啶联合亚叶酸钙与奥沙利铂化疗方案治疗晚期结直肠癌的临床研究

韩江琼 陈云兰 秦锴 牛义淳

中国临床药理学杂志Issue(8):674-675,678,3.
中国临床药理学杂志Issue(8):674-675,678,3.

5-氟尿嘧啶联合亚叶酸钙与奥沙利铂化疗方案治疗晚期结直肠癌的临床研究

Clinical study of 5 -FU/LV and L -OHP chemotherapy regimen for advanced colorectal cancer

韩江琼 1陈云兰 2秦锴 3牛义淳4

作者信息

  • 1. 昆明医科大学 第三附属医院 云南省肿瘤医院中西医结合科,昆明 650118
  • 2. 昆明医科大学 第三附属医院 干疗科,昆明 650118
  • 3. 都江堰市人民医院 普外科,四川 都江堰611830
  • 4. 昆明医科大学第二附属医院 消化科,昆明 650101
  • 折叠

摘要

Abstract

Objective To evaluate the efficacy and safety of two adju-vant chemotherapy regimens of 5-FU/LV and FOLFOX4 in patients with advanced colorectal cancer.Methods Ninety-nine patients with ad-vanced colorectal cancer were analyzed retrospectively.Of the 99 includ-ed patients , 45 were given the regimen of 5 FU/LV chemotherapy and other 54 subjects were given FOLFOX4 chemotherapy regimen.The clini-cal efficacy and adverse drug reactions in two groups were recorded and compared.Results The objective response rate ( ORR ) of FOLFOX4 group ( 50.0%) was much higher than 5 -FU/LV group ( 28.9%).The main adverse drug reactions were granulopenia and gastrointestinal reactions in the two groups , but there was no significant statistical differ-ence ( P>0.05 ).Conclusion Compared with advanced 5 -FU/LV chemotherapy regimen , FOLFOX4 therapy is more effective for patients with colorectal cancer , with similar incidence of adverse drug reactions.

关键词

结直肠癌/化疗方案/临床研究/5-氟尿嘧啶

Key words

advanced colorectal cancer/chemotherapy regimen/clinical study/5-FU

分类

医药卫生

引用本文复制引用

韩江琼,陈云兰,秦锴,牛义淳..5-氟尿嘧啶联合亚叶酸钙与奥沙利铂化疗方案治疗晚期结直肠癌的临床研究[J].中国临床药理学杂志,2014,(8):674-675,678,3.

基金项目

成都市卫生局科学研究基金资助项目 ()

中国临床药理学杂志

OA北大核心CSCDCSTPCD

1001-6821

访问量0
|
下载量0
段落导航相关论文